Anifrolumab Effects on Response to Influenza Vaccine in SLE

被引：0

作者：

Arriens, Cristina ^{[1
]}

Askanase, Anca ^{[2
]}

Machua, Wambui ^{[3
]}

Koumpouras, Fotios ^{[4
]}

Smith, Ken ^{[1
]}

Guthridge, Joel ^{[1
]}

James, Judith ^{[1
]}

Merrill, Joan ^{[1
]}

机构：

[1] Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA

[2] Columbia Univ, Med Ctr, New York, NY USA

[3] Piedmont Hosp Ctr, Atlanta, GA USA

[4] Yale Sch Med, New Haven, CT USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2424

引用

页码：4916 / 4918

页数：3

共 50 条

[1] Anifrolumab for SLE
Thorley, Jennifer
LANCET RHEUMATOLOGY, 2020, 2 (03): : E134 - E134
[2] EFFECTS OF ANIFROLUMAB ON RENAL DISEASE IN PATIENTS WITH SLE
Morand, E. F.
Furie, R.
Tanaka, Y.
Takeuchi, T.
Abreu, G.
Tummala, R.
Lindholm, C.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 592 - 593
[3] Anifrolumab bei SLE
rheuma plus, 2021, 20 (4) : 142 - 142
[4] Long-term anifrolumab for SLE
Thorley, Jennifer
LANCET RHEUMATOLOGY, 2025, 7 (03): : e162 - e162
[5] Disparate effects of immunosuppressants on influenza vaccine response.
Hayney, MS
Welter, DL
Francois, M
Reynolds, AM
Love, RB
PHARMACOTHERAPY, 2003, 23 (10): : 1367 - 1367
[6] Long-term anifrolumab safe in SLE
Jessica McHugh
Nature Reviews Rheumatology, 2023, 19 : 64 - 64
[7] Long-term anifrolumab safe in SLE
McHugh, Jessica
NATURE REVIEWS RHEUMATOLOGY, 2023, 19 (2) : 64 - 64
[8] Subcutaneous anifrolumab for SLE: a new step forward?
Costedoat-Chalumeau, Nathalie
Le Guern, Veronique
LANCET RHEUMATOLOGY, 2021, 3 (02): : E84 - E85
[9] Positive results for anifrolumab in phase III SLE trial
Onuora, Sarah
NATURE REVIEWS RHEUMATOLOGY, 2020, 16 (03) : 125 - 125
[10] VACCINE IMMUNE-RESPONSE AND SIDE-EFFECTS WITH THE USE OF ACETAMINOPHEN WITH INFLUENZA VACCINE
GROSS, PA
LEVANDOWSKI, RA
RUSSO, C
WEKSLER, M
BONELLI, J
DRAN, S
MUNK, G
DEICHMILLER, S
HILSEN, R
PANUSH, RF
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1994, 1 (02) : 134 - 138